Good news for Novartis as GSK's Mekinist/Tafinlar trial stopped early

 
• By Sukaina Virji
  
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anticancer

More from Therapy Areas